Home > Products > CD16 & GD2 > Recombinant Human Anti-CD16 x Human Anti-GD2 Bispecific Antibody (scFv-CH3)

Recombinant Human Anti-CD16 x Human Anti-GD2 Bispecific Antibody (scFv-CH3)  (CAT#: BSFC-H214)

Recombinant Anti-CD16 x Anti-GD2 Bispecific Antibody (scFv-CH3) contains two chains. The anti-CD16 scFv is fused to the Knob-CH3 domain via a hinge region and the same as the anti-GD2 scFv to the Hole-CH3 domain, or vice versa. The KIH CH3 domains can facilitate to form a heterodimer and this bivalent binding leads to improvement in avidity. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors therapy.
Datasheet INQUIRY

Specifications

Targets
CD16 & GD2
Type
scFv-based Bispecific Fragments
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors

Targets

Target 1
CD16
Gene ID
UniProt ID
Alternative Names
FCGR3A; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); CD16; FCG3; CD16A; FCGR3; IGFR3; IMD20; FCR-10; FCRIII; FCGRIII; FCRIIIA; low affinity immunoglobulin gamma Fc region receptor III-A; FcγRIII; FcgammaRIIIA; CD16a antigen; fc-gamma RIII; Fc-gamma RIIIa; Fc-gamma RIII-alpha; igG Fc receptor III-2; Fc gamma receptor III-A; Fc-gamma receptor IIIb (CD16); neutrophil-specific antigen NA; Fc-gamma receptor III-2 (CD 16); immunoglobulin G Fc receptor III; Fc fragment of IgG, low affinity III, receptor for (CD16)
Target 2
GD2
Alternative Names
Ganglioside GD2; GD2; Ganglioside; Disialoganglioside GD2
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD16 & GD2"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD16 x Human Anti-GD2 Bispecific Antibody (scFv-CH3) (BSFC-H214). Click the button below to contact us or submit your feedback about this product.